Lumos Pharma, Inc. (LUMO) - Balance Sheet Statement

Home
LUMO
Financials

4.36 (USD) • At close November 12, 2024

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
Assets:
Current Assets:
Cash & Cash Equivalents Numbers are in millions	35.078	56.007	94.809	98.679	90.549	120.738	158.708	131.49	195.62	190.404	61.291	20.25	39.49	10.572	15.217	6.276
Short Term Investments Numbers are in millions	0.999	11.352	0	0	0	0	0	0	2.18	12.393	0.249	1.494	2.49	2.269	0	0
Cash and Short Term Investments Numbers are in millions	36.077	67.359	94.809	98.679	90.549	120.738	158.708	131.49	197.8	202.797	61.54	21.744	39.49	12.841	15.217	6.276
Net Receivables Numbers are in millions	0.21	0.223	0.128	26.264	0.824	0.798	10.532	5.975	5.388	15.604	1.657	0.738	0.399	0.842	1.579	0.595
Inventory Numbers are in millions	0	0	0	0	0	0	0	0	-5.388	3.729	0	-0.738	0.409	0	0.11	0.05
Other Current Assets Numbers are in millions	3.748	4.427	4.74	3.506	3.046	5.536	6.226	30.447	10.342	8.333	0.773	1.645	2.49	0.959	1.992	1.85
Total Current Assets Numbers are in millions	40.035	72.009	99.677	128.449	94.419	127.072	175.466	167.912	208.142	230.463	63.97	23.389	42.788	14.642	18.898	8.771
Non-Current Assets:
Property, Plant & Equipment, Net Numbers are in millions	0.603	0.283	0.635	0.584	2.368	3.727	5.091	6.835	10.4	7.599	6.587	6.04	5.591	5.436	2.919	0.955
Goodwill Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Goodwill and Intangible Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long Term Investments Numbers are in millions	0	0	0	0	0	0.14	0.14	0	0	0	0	0	0	0	0	0
Tax Assets Numbers are in millions	0	0	0	0	0	0	0	0	0	15.604	0	0	0	0	0	0
Other Non-Current Assets Numbers are in millions	0	-0.283	-0.635	-0.584	0	0	0	0	0	-15.604	0	0	0	0	0.85	0.85
Total Non-Current Assets Numbers are in millions	0.603	0.283	0.635	0.584	2.368	3.867	5.231	6.835	10.4	7.599	6.587	6.04	5.591	5.436	3.769	1.805
Total Assets Numbers are in millions	40.638	72.292	100.312	129.033	96.787	130.939	180.697	174.747	218.542	238.062	70.557	29.429	48.379	20.078	22.667	10.576
Liabilities & Equity:
Current Liabilities:
Account Payables Numbers are in millions	0.89	0.275	0.612	0.244	0.475	0.555	9.256	22.883	12.422	2.412	3.473	0.972	1.67	0.552	1.08	0.601
Short Term Debt Numbers are in millions	0.282	0.233	0.352	0.319	1.143	0.061	0.16	0.232	0.571	0.192	0.189	0.204	6.214	0.207	0.035	0.004
Tax Payables Numbers are in millions	0	0	0	0	0.011	0	0	0	0.859	0	0.319	0	0	0	0	0
Deferred Revenue Numbers are in millions	0	0	0	0	0	0	0.056	0.391	0.892	12.966	0.084	0.084	0	0.951	0.947	1.237
Other Current Liabilities Numbers are in millions	4.968	5.925	3.554	5.654	9.723	7.676	3.303	-8.484	-12.326	7.12	-3.662	0.687	1.11	1.003	0.099	-0.595
Total Current Liabilities Numbers are in millions	7.03	6.708	5.13	6.461	11.827	8.847	22.031	37.905	14.84	25.102	3.876	2.919	10.664	3.265	3.241	1.848
Non-Current Liabilities:
Long Term Debt Numbers are in millions	6	6	0.205	6	0.082	0.043	0.111	0.285	0.368	0.86	7.033	7.178	0.942	7.087	6.078	6.004
Deferred Revenue Non-Current Numbers are in millions	0	0	0	0	0	0.906	0.998	1.091	0.407	1.085	1.321	1.405	-0.642	0	0	0
Deferred Tax Liabilities Non-Current Numbers are in millions	0	0	0	0	0	0	0	0	1.153	1.238	0.046	0.038	0.094	0	0	0
Other Non-Current Liabilities Numbers are in millions	0.303	0	6	0	6	6	6	6	6	6	-0.046	-0.038	0.548	61.745	54.134	34.554
Total Non-Current Liabilities Numbers are in millions	6.303	6	6.205	6	6.082	6.949	7.109	7.376	7.928	9.183	8.354	8.583	0.942	68.832	60.212	40.558
Total Liabilities Numbers are in millions	13.333	12.708	11.335	12.461	17.909	15.796	29.14	45.281	22.768	34.285	12.23	11.502	11.606	72.097	63.453	42.406
Equity:
Preferred Stock Numbers are in millions	0	0	0	129.033	63.535	60.495	57.454	0	0	0	0	0	0	1.03	1.03	1.03
Common Stock Numbers are in millions	0.081	0.082	0.083	0.083	0.374	0.373	0.372	0.292	0.288	0.28	0.266	0.21	0.206	0.036	0.067	0.066
Retained Earnings Numbers are in millions	-161.517	-127.483	-96.421	-65.991	-334.001	-291.012	-237.459	-165.508	-80.353	-33.119	-135.977	-104.797	-81.476	-63.389	-46.962	-37.52
Accumulated Other Comprehensive Income/Loss Numbers are in millions	-0	-0.009	0	-129.033	-63.535	-6.985	-6.638	-5.726	-6.516	0	0	0	0	-2.224	-1.569	-1.266
Other Total Stockholders Equity Numbers are in millions	188.741	186.994	185.315	182.48	412.505	352.272	337.828	300.408	282.355	236.616	194.038	122.514	118.043	9.585	4.296	3.318
Total Shareholders Equity Numbers are in millions	27.305	59.584	88.977	116.572	78.878	115.143	151.557	129.466	195.774	203.777	58.327	17.927	36.773	-54.962	-43.138	-34.372
Total Equity Numbers are in millions	27.305	59.584	88.977	116.572	78.878	115.143	151.557	129.466	195.774	203.777	58.327	17.927	36.773	-52.019	-40.786	-31.83
Total Liabilities & Shareholders Equity Numbers are in millions	40.638	72.292	100.312	129.033	96.787	130.939	180.697	174.747	218.542	238.062	70.557	29.429	48.379	20.078	22.667	10.576

Lumos Pharma, Inc.

NASDAQ:LUMO Add to watchlist

NASDAQ:LUMO